Ocaliva 5 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FYBGY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,320
Award facts
- Contract value 100% obligated
- $10,320.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order valued at $10,320.10 by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Ocaliva 5 mg tablets in quantities of 30 units. The contract carries a firm fixed-price structure with an ultimate completion date of September 10, 2025, and was awarded without any set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion agreement valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities nationwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in DLA procurement markets. The company's extensive portfolio with the Defense Logistics Agency encompasses prescription medications, biologics, over-the-counter products, and medical consumables across multiple therapeutic categories. This particular delivery order for Ocaliva tablets—used in the treatment of primary biliary cholangitis—reflects the company's ongoing role in supplying specialized pharmaceutical products to Department of Defense healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FYBGY?
SPE2DB25FYBGY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FYBGY worth?
The government has obligated $10,320 on SPE2DB25FYBGY.
Is contract SPE2DB25FYBGY an order under another contract?
Yes. SPE2DB25FYBGY is a delivery order under SPE2DB24D9313, an indefinite delivery contract.
Was contract SPE2DB25FYBGY competed?
The extent of competition for SPE2DB25FYBGY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award